Characterisation of the genomes of brain metastases
<p>Brain metastases are generally associated with a poor prognosis. The number of metastases, location and control of extracranial disease typically influences the management of patients. Treatment options are currently limited and are dependent on the clinical context. Interventions include s...
Auteur principal: | Ulahannan, D |
---|---|
Autres auteurs: | Tomlinson, I |
Format: | Thèse |
Publié: |
2015
|
Documents similaires
-
Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases
par: Marcin Nicoś, PhD, et autres
Publié: (2022-12-01) -
Proteomic and transcriptomic characterisation of FIA10, a novel murine leukemic cell line that metastasizes into the brain.
par: Ursula Just, et autres
Publié: (2024-01-01) -
Clinicopathologic and genomic characterizations of brain metastases using a comprehensive genomic panel
par: Duna H. Barakeh, et autres
Publié: (2022-11-01) -
Genomic landscape of the immune microenvironments of brain metastases in breast cancer
par: Wei-cheng Lu, et autres
Publié: (2020-08-01) -
Prevention of Brain Metastases
par: Joseph A. Bovi
Publié: (2018-09-01)